Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map)

NCT02154490 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT02154490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02154490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map)
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Completed
Start date
July 8, 2014
Completion date
April 15, 2022
Enrollment
1,864 (actual)
Sites
1,004

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent squamous cell lung carcinoma, stage iv squamous cell lung carcinoma ajcc v7